PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase I drugs for Pancreatic Ductal Adenocarcinoma does not ...

The only systematic review of PEP therapy in COPD [28] (n = 11 studies of 223 participants) found PEP mask therapy conferred small but significant short-term improvements in sputum expectoration ...

For example, combining a PEP device with nebulized medications ... Jet nebulizers remain the mainstay of aerosol therapy delivery in COPD, particularly during AECOPDs. This is despite evidence ...

PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase I drugs for Metastatic Ovarian Cancer have a 77% phase ...

thus far they have not provided evidence for MSC efficacy in the treatment of COPD. In this review, we discuss the rationale for MSC-based cell therapy in COPD, the main findings from in vitro and in ...